The Antibacterial Effect of Some Neuroleptics on Strains Isolated from Patients with Meningitis
- 1 December 1992
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 71 (6) , 449-451
- https://doi.org/10.1111/j.1600-0773.1992.tb00576.x
Abstract
Eighty‐two strains of bacteria (Neisseria meningitidis, Haemophilus influenzae, Enterobacteriaceae, Streptococcus pneumoniae, group B streptococci andListeria monocytogenes) were examined for theirin vitrosusceptibility to eight drugs, seven neuroleptics (perphenazine, fluphenazine, cis(Z)‐clopenthixol, haloperidol, clozapine, clebopride and SCH 23390), and the neuroleptically inactive trans(E)‐clopenthixol. The phenothiazines and the thioxanthenes were, on the whole, the most active drugs when measured, the IC5050for each group of bacteria being 7.4 to 84 mg/1 (with the exception of the activity against the enterobacteriaceae). The antibacterial potency of clozapine, which has an atypical neuroleptic profile, was between 50 and 140 mg/1. Haloperidol also showed an antibacterial activity in the concentration range 35‐140 mg/1. The selective D1antagonist, SCH 23390 and the selective D2antagonist, clebopride, inhibited only few of the bacteria in the concentration range investigated.Keywords
This publication has 6 references indexed in Scilit:
- Effect of Selected Neuroleptic Agents and Stereo‐Isomeric Analogues on Virus and Eukaryotic CellsBasic & Clinical Pharmacology & Toxicology, 1991
- The neuropharmacological profile of tefludazine, a potential antipsychotic drug with dopamine and serotonin receptor antagonistic effectsDrug Development Research, 1986
- Pharmacological Differentiation of Dopamine D-1 and D-2 Antagonists After Single and Repeated AdministrationPublished by Springer Nature ,1985
- Receptor-Binding Profiles of NeurolepticsPublished by Springer Nature ,1985
- Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neurolepticsLife Sciences, 1984
- SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.The Journal of Pharmacology and Experimental Therapeutics, 1983